News | April 28, 2026
Aurigene bets big on CRDMO expansion with $100 million outlay
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
The approval was driven by data from the Phase III TULIP-SC trial
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Subscribe To Our Newsletter & Stay Updated
